Citi analyst Yigal Nochomovitz raised the firm’s price target on Travere Therapeutics (TVTX) to $48 from $34 and keeps a Buy rating on the shares. Citi also added an “upside 90-day catalyst watch” on ...
Citi raised the firm’s price target on Vodafone (VOD) to 85 GBp from 75 GBp and keeps a Neutral rating on the shares. Citi also placed Vodafone on a “90-day negative catalyst watch” into the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results